Login to Your Account



Finnish startup closes $3.2M seed round for peptide-coated viruses

By Nuala Moran
Staff Writer

Tuesday, March 7, 2017

LONDON – Newco Valo Therapeutics Ltd. has spun out of Helsinki University, Finland, with €3 million of a first tranche of seed funding to commercialize next-generation peptide-coated oncolytic viruses that promote a specific antitumor immune activation.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription